Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 9/20 | 0.61 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.46 |
| ▸ | F2 | P00734 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6719902 | 0.94 | F10 (0.58) | F10ADORA2AKDM4EALDH1A1NPSR1 | |
| SCHEMBL6724192 | 0.92 | F10 (0.58) | F10ADORA2AKDM4EALDH1A1NPSR1 | |
| SCHEMBL6719376 | 0.92 | F10 (0.58) | F10ADORA2AKDM4EALDH1A1NPSR1 | |
| SCHEMBL6723916 | 0.90 | F10 (0.56) | F10ADORA2AKDM4EALDH1A1NPSR1 | |
| SCHEMBL6727095 | 0.89 | F10 (0.58) | F10ADORA2AKDM4EALDH1A1F2 | |
| SCHEMBL6726983 | 0.87 | F10 (0.48) | F10ADORA2AKDM4EF2SMN1; SMN2 | |
| SCHEMBL6724296 | 0.86 | F10 (0.50) | F10ADORA2AKDM4ECYP1A2CYP2C9 | |
| SCHEMBL6731298 | 0.86 | F10 (0.47) | F10ADORA2AKDM4EALDH1A1F2 | |
| SCHEMBL6719372 | 0.85 | ADORA2A (0.49) | F10ADORA2AKDM4EALDH1A1NPSR1 | |
| SCHEMBL6727221 | 0.85 | ADORA2A (0.49) | F10ADORA2AKDM4EALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6673745-B2 | Herbicidal 3,5-difluoropyridines | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-06 | — | — | US | claimed |
| EP-0887343-B1 | Herbicidal 3,5-difluoropyridines | BASF AG (DE) | 2003-06-11 | — | — | EP | claimed |
| US-20010011064-A1 | Herbicidal 3,5-difluoropyridines | AMERICAN CYANAMID COMPANY (US) | 2001-08-02 | — | — | US | claimed |
| EP-0887343-A1 | Herbicidal 3,5-difluoropyridines | American Cyanamid Company (US) | 1998-12-30 | — | — | EP | claimed |
| US-6673745-B2 | Herbicidal 3,5-difluoropyridines | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-06 | — | — | US | disclosed |
| EP-0887343-B1 | Herbicidal 3,5-difluoropyridines | BASF AG (DE) | 2003-06-11 | — | — | EP | disclosed |
| US-6310006-B1 | CONTROLLING WEEDS | AMERICAN CYANAMID COMPANY | 2001-10-30 | — | — | US | disclosed |
| US-20010011064-A1 | Herbicidal 3,5-difluoropyridines | AMERICAN CYANAMID COMPANY (US) | 2001-08-02 | — | — | US | disclosed |
| EP-0887343-A1 | Herbicidal 3,5-difluoropyridines | American Cyanamid Company (US) | 1998-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010011064-A1 | Herbicidal 3,5-difluoropyridines | DDT, CYP1B1, NQO2 | F10 4430/4885ADORA2A 1964/4885KDM4E 1341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.